期刊文献+

替勃龙联合更美宁胶囊治疗围绝经期综合征临床观察 被引量:1

Clinical Research on Treating Menopausal Syndrome by Tibolone Combined with Gengmeining Capsules
下载PDF
导出
摘要 目的:观察替勃龙(利维爱)联合更美宁胶囊治疗围绝经期综合征的临床疗效。方法:将110例患者随机分为治疗组及对照组。两组采用相同的基础治疗,对照组口服尼尔雌醇及安宫黄体酮。治疗组予利维爱及更美宁胶囊。两组均以3个月为1个疗程。结果:总有效率治疗组92.72%,优于对照组80.00%(P<0.05);两组对卵泡刺激素、黄体生成素和雌二醇具有相似的调节作用,但治疗组在降低临床症状积分方面更具优势;治疗后治疗组TG、TC、LDL-c均较治疗前显著降低(P<0.05),与对照组比较亦有显著性差异(P<0.05)。结论:利维爱联合更美宁胶囊治疗围绝经期综合征疗效确切,作用安全,值得推广。 Objective:To observe the clinical effect of tibolone combined with Gengmeining Capsules on the treatment of Menopausal Syndrome.Methods:110 cases of Menopausal Syndrome were randomly divided into two groups.Two groups used the same basic therapy.Patients in the control group were treated with Neil female alcohol and Ann palace progestin.The treatment group were treated by tibolone combined with Gengmeining Capsules.The clinical efficacy was evaluated after two cycles of chemotherapy.A course of treatment was 3 months.Results:The total effective rate of the treatment group 92.72%,better than control group80.00%(P〈0.05);There were similar regulatory role between two groups Including Follicle-stimulating hormone,corpus luteum erythropoietin and estradiol,but the treatment group in reducing the clinical symptom scores more advantages;The TG,TC,LDL-c in the treatment group significantly decreased after treatment(P〈0.05),compared with controls also significant difference(P〈0.05).Conclusion:Tibolone combined with Gengmeining Capsules is a relatively safe and efective regimen for patients with Menopausal Syndrome,is worthy to be popularized.
作者 秦柳平
出处 《中国医药导刊》 2012年第7期1194-1195,共2页 Chinese Journal of Medicinal Guide
关键词 利维爱 更美宁胶囊 围绝经期综合征 Tibolone Gengmeining Capsules Menopausal Syndrome
  • 相关文献

参考文献4

二级参考文献26

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3044
  • 2邵继红.20~59岁人群高尿酸血症的危险因素[J].中国全科医学,2004,7(22):1646-1647. 被引量:41
  • 3余俊文,陆锦波,张小娟,杨延斌,余寿益,刘奔流.1320名老年人血尿酸与血脂、血糖和血压的分析[J].中华流行病学杂志,2005,26(6):455-457. 被引量:98
  • 4沈自尹.补益药的临床研究思路.天津中医,1985,2(1):39-41.
  • 5曾庆馀.中国医学百科全书,风湿病学分册[M].上海:上海科学技术出版社,1988:44.
  • 6SUMINO H, ICHIKAWA S, KANDA T, et al. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia [ J ]. Lancet, 1999, 354 (9179) : 650 - 652.
  • 7NIETRO F J, IRIBARREN C, GROSS M D, et al. Uric acid andserum antioxidant capaticy:A reaction to atherosclerosis [ J]. Therosclerosis, 2000, 148( 1 ) : 131 - 139.
  • 8COSTA A, IGUALA I, BEDINI J, et al. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome [ J]. Metabolism, 2002, 51 (3) : 372 - 375.
  • 9LOHSOONT HORN V, DHANAMUN B, WILLIAMS M A. Prevalence of hyperuricemia and its relationship with metabolic syndrome in adults receiving annual health exams [ J ]. Arch Med Res, 2006, 37 (7) : 883 - 889.
  • 10FORD E S, GILES W H, DIETZ W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[ J]. JAMA, 2002, 287 (3): 356-359.

共引文献23

同被引文献29

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部